BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lapointe-Shaw L, Georgie F, Carlone D, Cerocchi O, Chung H, Dewit Y, Feld JJ, Holder L, Kwong JC, Sander B, Flemming JA. Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study. PLoS One 2018;13:e0201120. [PMID: 30133446 DOI: 10.1371/journal.pone.0201120] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Shaheen AA, Kong K, Ma C, Doktorchik C, Coffin CS, Swain MG, Burak KW, Congly SE, Lee SS, Sadler M, Borman M, Abraldes JG. Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01143-5. [PMID: 34715379 DOI: 10.1016/j.cgh.2021.10.030] [Reference Citation Analysis]
2 Abdel-qadir H, Austin PC, Pang A, Fang J, Udell JA, Geerts WH, Mcnaughton CD, Jackevicius CA, Kwong JC, Yeh CH, Cox JL, Lee DS, Ko DT, Atzema CL. The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study. Thrombosis Research 2022;211:114-22. [DOI: 10.1016/j.thromres.2021.12.010] [Reference Citation Analysis]
3 GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020;5:245-66. [PMID: 31981519 DOI: 10.1016/S2468-1253(19)30349-8] [Cited by in Crossref: 269] [Cited by in F6Publishing: 140] [Article Influence: 134.5] [Reference Citation Analysis]
4 Gu W, Hortlik H, Erasmus HP, Schaaf L, Zeleke Y, Uschner FE, Ferstl P, Schulz M, Peiffer KH, Queck A, Sauerbruch T, Brol MJ, Rohde G, Sanchez C, Moreau R, Arroyo V, Zeuzem S, Welsch C, Trebicka J. Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). Lancet Reg Health Eur 2022;12:100240. [PMID: 34901909 DOI: 10.1016/j.lanepe.2021.100240] [Reference Citation Analysis]
5 Alavi M, Law MG, Valerio H, Grebely J, Amin J, Hajarizadeh B, Selvey C, George J, Dore GJ. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia. Journal of Hepatology 2019;71:281-8. [DOI: 10.1016/j.jhep.2019.04.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
6 Shearer JE, Gonzalez JJ, Min T, Parker R, Jones R, Su GL, Tapper EB, Rowe IA. Systematic review: development of a consensus code set to identify cirrhosis in electronic health records. Aliment Pharmacol Ther 2022. [PMID: 35166399 DOI: 10.1111/apt.16806] [Reference Citation Analysis]
7 Wilton J, Samji H, Yu A, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort team. Reply to: "Pitfalls in measuring temporal trends for late diagnosis of viral hepatitis". J Hepatol 2019;71:1256-8. [PMID: 31653445 DOI: 10.1016/j.jhep.2019.09.015] [Reference Citation Analysis]
8 Lee DU, Fan GH, Hastie DJ, Addonizio EA, Prakasam VN, Ahern RR, Suh J, Seog KJ, Karagozian R. The clinical impact of cirrhosis on the postoperative outcomes of patients undergoing bariatric surgery: propensity score-matched analysis of 2011-2017 US hospitals. Expert Rev Gastroenterol Hepatol 2021;:1-10. [PMID: 33706616 DOI: 10.1080/17474124.2021.1902803] [Reference Citation Analysis]
9 Abdel-Qadir H, Singh SM, Pang A, Austin PC, Jackevicius CA, Tu K, Dorian P, Ko DT. Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc Factors. JAMA Cardiol 2021;6:918-25. [PMID: 34009232 DOI: 10.1001/jamacardio.2021.1232] [Reference Citation Analysis]
10 Flemming JA, Dewit Y, Mah JM, Saperia J, Groome PA, Booth CM. Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based study. Lancet Gastroenterol Hepatol 2019;4:217-26. [PMID: 30573390 DOI: 10.1016/S2468-1253(18)30339-X] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
11 Driver RJ, Balachandrakumar V, Burton A, Shearer J, Downing A, Cross T, Morris E, Rowe IA. Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study. BMJ Open 2019;9:e028571. [PMID: 31292182 DOI: 10.1136/bmjopen-2018-028571] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Jang SY, Rou WS, Kim SH, Lee BS, Eun HS. Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort study. Clin Mol Hepatol 2021;27:283-94. [PMID: 33317246 DOI: 10.3350/cmh.2020.0227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Gonzalez JJ, Dziwis J, Patel YA, Tapper EB. Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study. Dig Dis Sci 2022. [PMID: 35088187 DOI: 10.1007/s10620-021-07367-7] [Reference Citation Analysis]
14 Swain MG, Ramji A, Patel K, Sebastiani G, Shaheen AA, Tam E, Marotta P, Elkhashab M, Bajaj HS, Estes C, Razavi H. Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study. CMAJ Open 2020;8:E429-36. [PMID: 32518095 DOI: 10.9778/cmajo.20190212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
15 Davis TME, Peters KE, Chubb SAP, Adams LA, Jeffrey GP, Davis WA. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study. J Clin Med 2020;9:E3409. [PMID: 33114323 DOI: 10.3390/jcm9113409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Duarte NT, de Oliveira Godoy A, da Rocha Tenório J, Andrade NS, Franco JB, Pérez-sayáns M, Ortega KL. Prevalence of sublingual varices in patients with cirrhosis and the correlation with nitrogen compounds. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2020;129:39-44. [DOI: 10.1016/j.oooo.2019.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Mendlowitz A, Bremner KE, Walker JD, Wong WWL, Feld JJ, Sander B, Jones L, Isaranuwatchai W, Krahn M. Health care costs associated with hepatitis C virus infection in First Nations populations in Ontario: a retrospective matched cohort study. CMAJ Open 2021;9:E897-906. [PMID: 34584004 DOI: 10.9778/cmajo.20200247] [Reference Citation Analysis]
18 Hagström H, Adams LA, Allen AM, Byrne CD, Chang Y, Grønbaek H, Ismail M, Jepsen P, Kanwal F, Kramer J, Lazarus JV, Long MT, Loomba R, Newsome PN, Rowe IA, Ryu S, Schattenberg JM, Serper M, Sheron N, Simon TG, Tapper EB, Wild S, Wong VW, Yilmaz Y, Zelber-Sagi S, Åberg F. Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement. Hepatology 2021;74:474-82. [PMID: 33486773 DOI: 10.1002/hep.31726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Ames JB, Djerboua M, Terrault NA, Booth CM, Flemming JA, Peltekian KM. Rising Healthcare Costs and Utilization among Young Adults with Cirrhosis in Ontario: A Population-Based Study. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-13. [DOI: 10.1155/2022/6175913] [Reference Citation Analysis]
20 Greenaway E, Haines A, Ling SC, Krahn M. Treatment of Chronic Hepatitis C in Young Children Reduces Adverse Outcomes and Is Cost-Effective Compared to Deferring Treatment to Adulthood. J Pediatr. 2020;. [PMID: 32890583 DOI: 10.1016/j.jpeds.2020.08.088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
21 Flemming JA, Mullin M, Lu J, Sarkar MA, Djerboua M, Velez MP, Brogly S, Terrault NA. Outcomes of Pregnant Women With Cirrhosis and Their Infants in a Population-Based Study. Gastroenterology 2020;159:1752-1762.e10. [PMID: 32781083 DOI: 10.1053/j.gastro.2020.07.052] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
22 Huang AC, Grab J, Flemming JA, Dodge JL, Irani RA, Sarkar M. Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes. Am J Gastroenterol 2021. [PMID: 34928866 DOI: 10.14309/ajg.0000000000001590] [Reference Citation Analysis]
23 Flemming JA, Djerboua M, Groome PA, Booth CM, Terrault NA. NAFLD and Alcohol-Associated Liver Disease Will Be Responsible for Almost All New Diagnoses of Cirrhosis in Canada by 2040. Hepatology 2021. [PMID: 34174003 DOI: 10.1002/hep.32032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Adams PC, Richard L, Weir M, Speechley M. Survival and development of health conditions after iron depletion therapy in C282Y-linked hemochromatosis patients. CanLivJ 2021;4:381-90. [DOI: 10.3138/canlivj-2021-0016] [Reference Citation Analysis]
25 Abdel-Qadir H, Sabrie N, Leong D, Pang A, Austin PC, Prica A, Nanthakumar K, Calvillo-Argüelles O, Lee DS, Thavendiranathan P. Cardiovascular Risk Associated With Ibrutinib Use in Chronic Lymphocytic Leukemia: A Population-Based Cohort Study. J Clin Oncol 2021;39:3453-62. [PMID: 34464154 DOI: 10.1200/JCO.21.00693] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Dahiya M, Eboreime E, Hyde A, Rahman S, Sebastianski M, Carbonneau M, Tapper EB, Tandon P. International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases. Dig Dis Sci 2021. [PMID: 34091800 DOI: 10.1007/s10620-021-07076-1] [Reference Citation Analysis]
27 Mahmud N, Hubbard RA, Kaplan DE, Taddei TH, Goldberg DS. Risk prediction scores for acute on chronic liver failure development and mortality. Liver Int 2020;40:1159-67. [PMID: 31840390 DOI: 10.1111/liv.14328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
28 Bengtsson B, Askling J, Ludvigsson JF, Hagström H. Validity of administrative codes associated with cirrhosis in Sweden. Scandinavian Journal of Gastroenterology 2020;55:1205-10. [DOI: 10.1080/00365521.2020.1820566] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
29 Yang JY, Moon AM, Kim H, Pate V, Barritt AS 4th, Crowley MJ, Buse JB, Stürmer T, Alexopoulos AS. Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes. J Diabetes Complications 2020;34:107706. [PMID: 32843283 DOI: 10.1016/j.jdiacomp.2020.107706] [Reference Citation Analysis]
30 Flemming JA, Muaddi H, Djerboua M, Neves P, Sapisochin G, Selzner N. Association between social determinants of health and rates of liver transplantation in individuals with cirrhosis. Hepatology 2022. [PMID: 35313040 DOI: 10.1002/hep.32469] [Reference Citation Analysis]
31 Mir ZM, Djerboua M, Nanji S, Flemming JA, Groome PA. Predictors of Postoperative Liver Decompensation Events After Resection in Patients with Cirrhosis and Hepatocellular Carcinoma: A Population-Based Study. Ann Surg Oncol 2021. [PMID: 34549362 DOI: 10.1245/s10434-021-10801-9] [Reference Citation Analysis]
32 Mah JM, Dewit Y, Groome P, Djerboua M, Booth CM, Flemming JA. Early hospital readmission and survival in patients with cirrhosis: A population-based study. CanLivJ 2019;2:109-20. [DOI: 10.3138/canlivj.2018-0025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
33 Mahmud N, Asrani SK, Kaplan DE, Ogola GO, Taddei TH, Kamath PS, Serper M. The Predictive Role of Model for End-Stage Liver Disease-Lactate and Lactate Clearance for In-Hospital Mortality Among a National Cirrhosis Cohort. Liver Transpl 2021;27:177-89. [PMID: 33025731 DOI: 10.1002/lt.25913] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Mah JM, DeWit Y, Djerboua M, Menard A, Booth CM, Flemming JA. Association Between Institutional Factors and Long-Term Survival Following Transjugular Intrahepatic Portosystemic Shunt. Hepatol Commun 2019;3:838-46. [PMID: 31168517 DOI: 10.1002/hep4.1345] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
35 Lapointe-Shaw L, Chung H, Holder L, Kwong JC, Sander B, Austin PC, Janssen HLA, Feld JJ. Diagnosis of Chronic Hepatitis B Peri-Complication: Risk factors and Trends over Time. Hepatology. 2020;. [PMID: 32931613 DOI: 10.1002/hep.31557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Carbonneau M, Eboreime EA, Hyde A, Campbell-scherer D, Faris P, Gramlich L, Tsuyuki RT, Congly SE, Shaheen AA, Sadler M, Zeman M, Spiers J, Abraldes JG, Sugars B, Sia W, Green L, Abdellatif D, Schaefer JP, Selvarajah V, Marr K, Ryan D, Westra Y, Bakshi N, Varghese JC, Tandon P. The cirrhosis care Alberta (CCAB) protocol: implementing an evidence-based best practice order set for the management of liver cirrhosis - a hybrid type I effectiveness-implementation trial. BMC Health Serv Res 2020;20. [DOI: 10.1186/s12913-020-05427-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Patidar KR, Adibuzzaman M, Naved MA, Rodriquez D, Slaven JE, Grama A, Desai AP, Gomez EV, Ghabril MS, Nephew L, Samala NR, Anderson M, Chalasani NP, Orman ES. Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury. Liver Int 2022;42:187-98. [PMID: 34779104 DOI: 10.1111/liv.15096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Xiao KY, Hubbard RA, Kaplan DE, Taddei TH, Goldberg DS, Mahmud N. Models for acute on chronic liver failure development and mortality in a veterans affairs cohort. Hepatol Int 2020;14:587-96. [PMID: 32519219 DOI: 10.1007/s12072-020-10060-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Bloom PP, Tapper EB. The Use of Administrative Data to Investigate the Population Burden of Hepatic Encephalopathy. J Clin Med 2020;9:E3620. [PMID: 33182743 DOI: 10.3390/jcm9113620] [Reference Citation Analysis]
40 Roberts SB, Hansen BE, Shin S, Abrahamyan L, Lapointe-Shaw L, Janssen HLA, Razak F, Verma AA, Hirschfield GM. Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort. Aliment Pharmacol Ther 2021;54:689-98. [PMID: 34181776 DOI: 10.1111/apt.16488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Burkholder DA, Moran IJ, DiBattista JV, Lok AS, Parikh ND, Chen VL. Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications. Dig Dis Sci 2021. [PMID: 34674069 DOI: 10.1007/s10620-021-07282-x] [Reference Citation Analysis]
42 Zhu P, Liu Z, Zhou J, Chen Y. Tanshinol inhibits the growth, migration and invasion of hepatocellular carcinoma cells via regulating the PI3K-AKT signaling pathway. Onco Targets Ther 2019;12:87-99. [PMID: 30588033 DOI: 10.2147/OTT.S185997] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
43 Rodrigues DM, Djerboua M, Flemming JA. Intravenous Albumin in Patients With Cirrhosis: Evaluation of Practice Patterns and Secular Trends of Usage in Ontario 2000 to 2017. J Can Assoc Gastroenterol 2021;4:179-85. [PMID: 34337318 DOI: 10.1093/jcag/gwaa027] [Reference Citation Analysis]
44 Hamadeh A, Haines A, Feng Z, Thein HH, Janjua NZ, Krahn M, Wong WWL. Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population-based cohort studies. J Viral Hepat 2020;27:1419-29. [PMID: 32810886 DOI: 10.1111/jvh.13373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
45 Lapointe-Shaw L, Chung H, Sander B, Kwong JC, Holder L, Cerocchi O, Austin PC, Feld JJ. Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over time. Liver Int 2021;41:33-47. [PMID: 32956567 DOI: 10.1111/liv.14670] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Wang PL, Silver SA, Djerboua M, Thanabalasingam S, Zarnke S, Flemming JA. Recovery From Acute Kidney Injury Requiring Dialysis in Patients With Cirrhosis: A Population-Based Study. Am J Kidney Dis 2021:S0272-6386(21)01000-3. [PMID: 34808296 DOI: 10.1053/j.ajkd.2021.09.025] [Reference Citation Analysis]
47 Wong WWL, Haines A, Bremner KE, Yao Z, Calzavara A, Mitsakakis N, Kwong JC, Sander B, Thein HH, Krahn MD. Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study. CMAJ Open 2021;9:E167-74. [PMID: 33688024 DOI: 10.9778/cmajo.20200162] [Reference Citation Analysis]
48 Lapointe-shaw L, Austin PC, Chung H, Sander B, Kwong JC, Feld JJ. Pitfalls in measuring temporal trends for late diagnosis of viral hepatitis. Journal of Hepatology 2019;71:1251-4. [DOI: 10.1016/j.jhep.2019.06.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Wang PL, Flemming JA. Addressing the global cirrhosis epidemic: one size will not fit all. Lancet Gastroenterol Hepatol 2020;5:230-1. [PMID: 31981522 DOI: 10.1016/S2468-1253(19)30382-6] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]